Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dorval

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancerM Robain, J Y Pierga, M Jouve, et al.
Cancer Treatment Reports|October 1, 1982
Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot studyD Machover, L Schwarzenberg, E Goldschmidt, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
An intensive care chemo- or chemoimmunotherapy regimen for patients with intermediate and poor-prognosis acute lymphatic leukemia and leukemic lymphoblastic lymphosarcoma: preliminary results with 14-month median follow-upJ L Misset, F De Vassal, M Delgado, et al.
British Journal of Cancer|July 4, 1998
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90)J Y Pierga, M Jouve, B Asselain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patientsJ Y Pierga, M Robain, M Jouve, et al.
Cancer|March 26, 1999
Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel studyT Dorval, S Négrier, C Chevreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2010
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experienceL Staudacher, P H Cottu, V Diéras, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6S M Scholl, A Fourquet, B Asselain, et al.
Anticancer Research|March 1, 1983
Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancerV Georgoulias, J L Misset, P Ribaud, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Breast tumour response to primary chemotherapy predicts local and distant control as well as survivalS M Scholl, J Y Pierga, B Asselain, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancerM Robain, J Y Pierga, M Jouve, et al.
Cancer Treatment Reports|October 1, 1982
Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot studyD Machover, L Schwarzenberg, E Goldschmidt, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
An intensive care chemo- or chemoimmunotherapy regimen for patients with intermediate and poor-prognosis acute lymphatic leukemia and leukemic lymphoblastic lymphosarcoma: preliminary results with 14-month median follow-upJ L Misset, F De Vassal, M Delgado, et al.
British Journal of Cancer|July 4, 1998
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90)J Y Pierga, M Jouve, B Asselain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patientsJ Y Pierga, M Robain, M Jouve, et al.
Cancer|March 26, 1999
Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel studyT Dorval, S Négrier, C Chevreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2010
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experienceL Staudacher, P H Cottu, V Diéras, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6S M Scholl, A Fourquet, B Asselain, et al.
Anticancer Research|March 1, 1983
Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancerV Georgoulias, J L Misset, P Ribaud, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Breast tumour response to primary chemotherapy predicts local and distant control as well as survivalS M Scholl, J Y Pierga, B Asselain, et al.
Pageof 11